“What CITI Program is Reading” is our biweekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for upcoming editions and more information from CITI Program.
FDA expands approval of CRISPR-based medicine to treat beta thalassemia
Source: STAT The FDA approved a CRISPR-based medicine to treat beta thalassemia, an inherited blood disorder. It’s the same potentially curative therapy cleared by the FDA to treat sickle cell disease.
(Login may be required)
Read The Full Article
New NIH chief opens up about risky pathogens, postdoc salaries and the year ahead
Source: Nature Nature talks to Monica Bertagnolli about hot-button issues and her top priorities for 2024.
Read The Full Article
A Flaw in Millions of Apple, AMD, and Qualcomm GPUs Could Expose AI Data
Source: Wired Patching every device affected by the LeftoverLocals vulnerability—which includes some iPhones, iPads, and Macs—may prove difficult.
(Login may be required)
Read The Full Article
Cleaning Tasks and Products and Asthma Among Health Care Professionals
Source: Journal of Occupational and Environmental Medicine We estimated asthma prevalence by professional group and explored associations of self-reported asthma with job-exposure matrix–based cleaning tasks/products in a representative Texas sample of 9914 physicians, nurses, respiratory/occupational therapists, and nurse aides.
Read The Full Article
Plagiarism Detection Tools Offer a False Sense of Accuracy
Source: The Markup The tools that likely brought down Harvard president Claudine Gay are improperly used on students all the time.
Read The Full Article
Doing your own research is a good way to end up being wrong
Source: The Washington Post The mantra of the internet era is that the abundance of information allows people to be better informed. That’s not always true.
(Login may be required)
Read The Full Article
What Eli Lilly’s Zepbound reveals about the intricate process of naming drugs today
Source: STAT The story behind the Zepbound moniker offers insight into the marketing differences between the U.S. and Europe, as well as how drug names are developed today.
(Login may be required)
Read The Full Article
Challenges meeting U.S. ClinicalTrials.gov reporting requirements
Source: CTTI Timely, accurate, and complete registration and reporting of summary results information for applicable clinical trials on ClinicalTrials.gov is an important part of providing patients, providers, researchers, and the public with access to information about clinical trials and their results.
Read The Full Article
Brain Navi’s neurosurgical robot used in 100th surgical procedure
Source: Medical Device Network Brain Navi plans to submit a 510(k) application to the US Food and Drug Administration later this year for its CE marked NaoTrac robot.
Read The Full Article
